HILE(SH:603718) Ge Long Hui A P P·2025-12-16 09:08Core Viewpoint - Hai Li Biological (603718.SH) announced that its subsidiary, Ruisheng Biological, received approval from the Indonesian Ministry of Health (MOH) for its GORORISE Natural Bone Grafting Material, indicating a significant milestone in expanding its product offerings in the Southeast Asian market [1] Group 1: Product Development and Approval - Ruisheng Biological submitted the registration application for GORORISE Natural Bone Grafting Material to the Indonesian MOH in August 2025 [1] - The GORORISE product is an animal-derived bone repair material that closely resembles human natural bone tissue in composition and microstructure [1] - The product is designed for maxillary bone defect repair and promotes new bone generation through its interconnected porous structure and natural components, showcasing strong potential for clinical application and market expansion [1] Group 2: Regulatory Milestones - GORORISE Natural Bone Grafting Material received its Class III medical device registration certificate from the National Medical Products Administration of China in December 2013 [1] - The product also obtained a Class D medical device registration certificate in Indonesia in December 2025 [1]